DK2992899T3 - Forøget immunrespons hos fuglearter - Google Patents

Forøget immunrespons hos fuglearter Download PDF

Info

Publication number
DK2992899T3
DK2992899T3 DK15178476.6T DK15178476T DK2992899T3 DK 2992899 T3 DK2992899 T3 DK 2992899T3 DK 15178476 T DK15178476 T DK 15178476T DK 2992899 T3 DK2992899 T3 DK 2992899T3
Authority
DK
Denmark
Prior art keywords
immune response
increased immune
bird species
bird
species
Prior art date
Application number
DK15178476.6T
Other languages
English (en)
Inventor
Albert Abraham
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Application granted granted Critical
Publication of DK2992899T3 publication Critical patent/DK2992899T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55561CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK15178476.6T 2009-05-14 2010-05-07 Forøget immunrespons hos fuglearter DK2992899T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17809909P 2009-05-14 2009-05-14
EP10720350.7A EP2429581B1 (en) 2009-05-14 2010-05-07 Enhanced immune response in avian species

Publications (1)

Publication Number Publication Date
DK2992899T3 true DK2992899T3 (da) 2020-09-14

Family

ID=42357738

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10720350.7T DK2429581T3 (da) 2009-05-14 2010-05-07 Forbedret immunrespons hos fuglearter
DK15178476.6T DK2992899T3 (da) 2009-05-14 2010-05-07 Forøget immunrespons hos fuglearter

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10720350.7T DK2429581T3 (da) 2009-05-14 2010-05-07 Forbedret immunrespons hos fuglearter

Country Status (35)

Country Link
US (1) US20120064151A1 (da)
EP (2) EP2429581B1 (da)
JP (1) JP5679589B2 (da)
KR (2) KR20170102379A (da)
CN (2) CN102427827B (da)
AR (1) AR076767A1 (da)
AU (1) AU2010246652B2 (da)
BR (1) BRPI1010803A2 (da)
CA (1) CA2761736C (da)
CL (1) CL2011002808A1 (da)
CO (1) CO6460752A2 (da)
CR (1) CR20110595A (da)
DK (2) DK2429581T3 (da)
EC (1) ECSP11011448A (da)
ES (2) ES2550181T3 (da)
HK (1) HK1168032A1 (da)
HR (2) HRP20151117T1 (da)
HU (2) HUE025765T2 (da)
IL (1) IL215900A (da)
LT (1) LT2992899T (da)
MX (1) MX336019B (da)
MY (1) MY162561A (da)
NI (1) NI201100196A (da)
NZ (1) NZ596366A (da)
PE (1) PE20120903A1 (da)
PL (2) PL2992899T3 (da)
PT (2) PT2429581E (da)
RU (1) RU2570732C9 (da)
SI (2) SI2992899T1 (da)
SV (1) SV2011004056A (da)
TW (1) TWI555846B (da)
UA (1) UA106076C2 (da)
UY (1) UY32634A (da)
WO (1) WO2010130374A1 (da)
ZA (1) ZA201107827B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2719614C (en) * 2008-03-25 2018-05-01 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
NZ612285A (en) 2010-12-22 2015-09-25 Bayer Ip Gmbh Enhanced immune response in bovine species
JO3733B1 (ar) 2011-04-05 2021-01-31 Bayer Ip Gmbh استخدام 3,2-دايهيدروايميدازو[1, 2 -c]كوينازولينات مستبدلة
CN103721253B (zh) * 2014-01-02 2015-06-10 青岛易邦生物工程有限公司 一种禽脑脊髓炎和鸡痘二联活疫苗
MX2016010993A (es) * 2014-02-28 2017-05-01 Bayer Animal Health Gmbh Plasmidos inmunoestimuladores.
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
EP3313376A2 (en) * 2015-06-26 2018-05-02 Bayer Animal Health GmbH Methods of modulating cytosolic dna surveillance molecules
AU2016304343A1 (en) * 2015-07-31 2018-02-08 Bayer Animal Health Gmbh Enhanced immune response in aquatic species
MX2018001251A (es) * 2015-07-31 2018-03-26 Bayer Animal Health Gmbh Respuesta inmunitaria potenciada de las especies porcinas.
CA3031778A1 (en) 2016-07-26 2018-02-01 Bayer Animal Health Gmbh Increased fertility in bovine species
JP7458977B2 (ja) * 2017-12-15 2024-04-01 エランコ アニマル ヘルス ゲー・エム・ベー・ハー 免疫刺激性組成物
CN114467855A (zh) * 2022-01-14 2022-05-13 广东海大集团股份有限公司 一种多病因气囊炎雏鸡模型的构建方法及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5427791A (en) 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
ATE272410T1 (de) * 1999-03-26 2004-08-15 Vical Inc Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
CA2395840A1 (en) * 1999-12-27 2001-07-05 The University Of Manitoba Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens
US20050181035A1 (en) * 2004-02-17 2005-08-18 Dow Steven W. Systemic immune activation method using non CpG nucleic acids
CA2719614C (en) * 2008-03-25 2018-05-01 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)

Also Published As

Publication number Publication date
PE20120903A1 (es) 2012-08-01
RU2570732C2 (ru) 2015-12-10
ZA201107827B (en) 2012-12-27
US20120064151A1 (en) 2012-03-15
AU2010246652A1 (en) 2011-11-17
CN102427827A (zh) 2012-04-25
PL2429581T3 (pl) 2016-01-29
ES2550181T3 (es) 2015-11-05
AU2010246652B2 (en) 2014-10-02
CN104906573A (zh) 2015-09-16
SV2011004056A (es) 2012-03-14
MX2011011931A (es) 2011-12-06
AR076767A1 (es) 2011-07-06
KR101966989B1 (ko) 2019-04-08
CA2761736C (en) 2017-09-26
MY162561A (en) 2017-06-30
KR20120027345A (ko) 2012-03-21
IL215900A0 (en) 2012-01-31
CO6460752A2 (es) 2012-06-15
NZ596366A (en) 2013-12-20
TW201043698A (en) 2010-12-16
BRPI1010803A2 (pt) 2018-06-12
KR20170102379A (ko) 2017-09-08
CA2761736A1 (en) 2010-11-18
HRP20201554T1 (hr) 2020-12-11
CL2011002808A1 (es) 2012-07-13
LT2992899T (lt) 2020-10-26
HK1168032A1 (zh) 2012-12-21
PL2992899T3 (pl) 2021-04-06
UY32634A (es) 2010-12-31
UA106076C2 (uk) 2014-07-25
CR20110595A (es) 2012-03-09
SI2992899T1 (sl) 2020-10-30
CN102427827B (zh) 2015-07-22
PT2992899T (pt) 2020-09-21
HRP20151117T1 (hr) 2015-11-20
SI2429581T1 (sl) 2015-11-30
RU2011150529A (ru) 2013-06-20
HUE025765T2 (en) 2016-05-30
DK2429581T3 (da) 2015-11-09
PT2429581E (pt) 2015-11-02
MX336019B (es) 2016-01-06
ES2808827T3 (es) 2021-03-02
WO2010130374A1 (en) 2010-11-18
IL215900A (en) 2017-07-31
JP5679589B2 (ja) 2015-03-04
EP2429581A1 (en) 2012-03-21
JP2012526734A (ja) 2012-11-01
EP2992899A1 (en) 2016-03-09
RU2570732C9 (ru) 2016-09-10
EP2429581B1 (en) 2015-08-05
NI201100196A (es) 2012-06-06
EP2992899B1 (en) 2020-07-01
HUE051005T2 (hu) 2021-01-28
TWI555846B (zh) 2016-11-01
ECSP11011448A (es) 2011-12-30

Similar Documents

Publication Publication Date Title
DK2992899T3 (da) Forøget immunrespons hos fuglearter
HK1259341A1 (zh) 牛物種中增强的免疫應答
DK2273004T3 (da) Rensesystem
DK2416897T4 (da) Skylleindretning
BRPI1007679A2 (pt) carpete
FI20095112A0 (fi) Eläinravinto
BRPI1009979A2 (pt) aveso
BRPI0921161A2 (pt) teteira
FR2934783B3 (fr) Tire-lait
DK2438082T3 (da) Rekombinant-fremstillede allergener
DE102010002918A8 (de) Briefkastenanlage
TH115082B (th) ตู้จดหมาย
ES1070232Y (es) Troceadora de pollos asados
IT1398900B1 (it) Gruppo di pastorizzazione
TH127661B (th) ตู้จดหมาย
TH117201B (th) ตู้จดหมาย
TH107136B (th) แจกัน
TH111938B (th) แจกัน
TH102344B (th) ช้อน
TH102884B (th) ช้อน
TH110847B (th) ช้อน
TH111294B (th) ช้อน
ES1070027Y (es) Posavasos
UA18759S (uk) Пуфик
UA19555S (uk) Диван